PODCAST: COVID-19 nutra round-ups from Kirin, GN Corporation, MGC Pharma

By Tingmin Koe

- Last updated on GMT

PODCAST: COVID-19 nutra round-ups from Kirin, GN Corporation, MGC Pharma

Related tags COVID-19 Podcast

In this podcast, explore the latest COVID-19 and nutra developments from Japan firms Kirin, GN Corporation, and ASX-listed MGC Pharma.

Both Kirin and GN Corporation have recently announced new COVID-19 research endeavours using their existing health supplements.

For GN Corporation​, it showed that intake of its beta-glucan products could reduce inflammatory biomarkers in COVID-19 patients compared to just the standard treatment alone.

This is according to its trial conducted in India and involved 40 patients with mild to moderate COVID-19.

Kirin, on the other hand, is assessing if Lactococcus lactis ​Strain Plasma – which it has been researching since 2010, could alleviate mild COVID-19 symptoms. 

The strain has been found to activate plasma cytoid dendritic cells (pDCs), also known as the command center of the immune system responsible for the defense against viral infections.

The 14-day trial​ will be jointly conducted with Nagasaki University.

Lastly, MGC Pharmaceuticals said in January that it has received an import approval from the Food Safety and Standards Authority of India (FSSAI) for its proprietary food supplement ArtemiC Rescue.

The product, which contains artemisinin, curcumin, Boswellia serrata, and vitamin C, has been proven in a phase II clinical trial involving 50 patients in India and Israel in 2020.

According to the trial results, none in the intervention group required additional oxygen, mechanical ventilation or admission to the ICU, but all of these events were reported in the placebo group.

The company has also embarked on another clinical trial to test out the formula’s effect in alleviating symptoms of long COVID syndrome.

Listen to the podcast to find out more.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Gencor Pacific Limited

Gencor Pacific Limited

Content provided by Gencor | 05-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

Related suppliers

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast